One of the aggravators of endometrial or ovarian cancer is the high percentage of patients who are not diagnosed correctly and end up with an unfavourable evolution and recurrence.  That is why the group works to identify and characterise new molecules, which could play a relevant role in neoplastic cell transformation and/or the growth, progression and dissemination of this type of tumour, as well as resistance to current therapies. They also develop new clinically relevant tools, instruments to improve the clinical management of patients, in close collaboration with clinical, basic and translational researchers, to focus all projects on responding to clinical needs. As well as cancers, the group directs its research towards other gynaecological illnesses like endometriosis.

Visit the research group’s page

 

 

Serveis
Ponderació
9

Subscribe to our newsletters and be a part of Campus Life

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.